SOME INDICATORS OF HUMORAL IMMUNITY AND MICROBIOCENOSIS CONDITION OF REPRODUCTIVE PATHWAYS OF WOMEN-INTERNALLY DISPLACED PERSONS WITH THREATENED MISCARRIAGE

Authors

  • A. V. Boychuk I. Horbachevsky Ternopil National Medical University
  • I. Yu. Romanenko Ukrainian Scientific and Practical Center for Endocrine Surgery, Transplantation of Endocrine Organs and Tissues, Kyiv

DOI:

https://doi.org/10.11603/24116-4944.2020.2.11838

Keywords:

pregnancy, threatened miscarriage, microbiocenosis, laboratory diagnostics

Abstract

The aim of the study – to learn the microbiocenosis of the reproductive tract and indicators of humoral immunity of women-internally displaced persons (IDPs) with a threatened miscarriage (TM) in order to improve treatment and prophylactic measures and prevent obstetric and perinatal complications.

Materials and Methods. The study included 51 pregnant women in the first and second trimesters who were hospitalized regarding TM to the hospitals, located in Luhansk region, and who had the IDP status (group I). The control group (group II) consisted of 64 pregnant women with non-complicated obstetric anamnesis and physiological course of pregnancy with similar gestational age and place of residence. A comprehensive clinical and laboratory examination, assessment of the vaginal biocenosis by the bacterioscopic method and determination of immunoglobulins of class Ig G to Herpes simplex virus types I-II (HSV), Cytomegalovirus (CMV) and Epstein-Barr virus (EBV) were carried out.

Results and Discussion. The number of cases of nonspecific vaginitis and bacterial vaginosis was significantly more frequent (p<0.05) in women of group I (23.53 % vs 9.38 % and 19.61 % vs 6.25 %, respectively), normocenosis was significantly more frequent (p<0.05) in group II (82.81 % vs 52.94 %, respectively). Anti-Ig G HSV was detected in 90.32 % in group I and in 95.24 % in group II, anti-IgG CMV – in 80.65 % and 85.71 %, anti-IgG to the capsid antigen EBV VCA – in 74.19 % and 71.43 % of cases, respectively, antibodies to early EBV antigens (anti-IgG EBV EA) were absent in all pregnant women. The combination of anti-IgG HSV + anti-IgG CMV was noted in 70.97 % and 71.43 %, anti-IgG HSV seropositivity + anti-IgG CMV + anti-IgG EBV VCA – in 48.39 % and 52.38 % of cases respectively.

Conclusions. The prevalence of microbiocenosis disorders among pregnant women with TM in I and II trimesters and IDP status was 47.06 %. Antenatal assessment of the serological status and the state of the vaginal biocenosis at the beginning of pregnancy, regardless of clinical symptoms, will allow to individualize the approach to the management of pregnancy and, if needed, to timely develop corrective measures that will contribute to a successful outcome of the pregnancy and influence the health of the mother and her offspring

Author Biographies

A. V. Boychuk, I. Horbachevsky Ternopil National Medical University

Doctor of Medical Sciences, Professor, Head Department of Obstetrics and Gynaecology, Institute of Postgraduate Education I. Horbachevsky Ternopil National Medical University

I. Yu. Romanenko, Ukrainian Scientific and Practical Center for Endocrine Surgery, Transplantation of Endocrine Organs and Tissues, Kyiv

PhD in Medicine, Associate Professor, leading researcher of the Department of Reproductive Medicine and Surgery of the Ukrainian Scientific and Practical Center for Endocrine Surgery, Transplantation of Endocrine Organs and Tissues of the Ministry of Health of Ukraine, Kyiv

References

IDCP Global Overview 2015: People internally displaced by conflict and violence (2015). Retrieved from: http://www.internal-displacement.org/sites/default/files/inline-files/20150506-global-overview-2015-en.pdf.

Forced displacement in 2018. Global trends. Retrieved from: https://www.unhcr.org/globaltrends2018/.

Global Report on Internal Displacement 2019. Retrieved from: http://www.internal-displacement.org/sites/default/files/publications/documents/2019-IDMC-GRID.pdf.

UNHCR, the UN Refugee Agency. 2020. Retrieved from: https://www.unhcr.org/ua/ %D0 %B2 %D0 %BD %D1 %83 %D1 %82 %D1 %80 %D1 %96 %D1 %88 %D0 %BD %D1 %8C %D0 %BE- %D0 %BF %D0 %B5 %D1 %80 %D0 %B5 %D0 %BC %D1 %96 %D1 %89 %D0 %B5 %D0 %BD %D1 %96- %D0 %BE %D1 %81 %D0 %BE %D0 %B1 %D0 %B8- %D0 %B2 %D0 %BF %D0 %BE#.

Keren, M., Keren, N., Eden, A., Tsangen, S., Weizman, A., & Zalsman, G. (2015). The complex impact of five years of stress related to life-threatening events on pregnancy outcomes: a preliminary retrospective study. Eur. Psychiatry, 30 (2), 317-321. DOI:10.1016/j.eurpsy.2014.10.004.

Morina, N., Akhtar, A., Barth, J., & Schnyder, U. (2018). Psychiatric disorders in refugees and internally displaced persons after forced displacement: a systematic review. Front. Psychiatry, 9, 433. DOI:10.3389/fpsyt.2018.00433.

Romanenko, I.Yu. (2019). Psykhoemotsiinyi stan zhinok-vnutrishno peremishchenykh osib iz zahrozoiu pereryvannia vahitnosti, yaki prozhyvaiut v Luhanskii oblasti [Psychoemotional state of women-internally displaced persons with a threatened miscarriage, living in the Luhansk region]. Svit medytsyny ta biolohii – World of Medicine and Biology, 68 (2), 105-109. DOI: 10.26724/2079-8334-2019-2-68-105-109 [in Ukrainian].

Ectopic pregnancy and miscarriage (NICE clinical guideline 154). Royal College of Obstetricians and Gynaecologists (2012). Retrieved from: https://www.rcog.org.uk/en/guidelines-research-services/guidelines/ectopic-pregnancy-and-miscarriage-nice-clinical-guideline-154.

Ahmed. S.R., El-Khatem El-Sammani, M., Al-Alaziz Al-Sheeha, M., Aitallah, A.S., Farhat Jabin Khan, Salah Roshdy Ahmed (2012). Pregnancy outcome in women with threatened miscarriage: a year study. Mater. Sociomed., 24 (1), 26-28. DOI:10.5455/msm.2012.24.26-28.

Weiss, J.L., Malone, F.D., Vidaver, J., Ball, R.H., Nyberg, D.A., Comstock, C.H., & DAlton, M.E. (2004). Threatened abortion: A risk factor for poor pregnancy outcome, a population-based screening study. Am. J. Obstet. Gynecol., 190, 745-750. DOI:10.1016/j.ajog.2003.09.023.

Kanmaz, A.G., İnan, A.H., Beyan, E., & Budak, A. (2019). The effects of threatened abortions on pregnancy outcomes. Ginekol Pol., 90 (4), 195-200. DOI:10.5603/GP.a2019.0035.

Mansour, F., Yousif, A., & Farag, D.S. (2018). Predicting adverse maternal and neonatal outcome in women with threatened abortion and patient compliance to its management. Am. J. Nurs. Res., 6 (6), 562-567. DOI:10.12691/ajnr-6-6-26.

Basama, F.M.S., & Crosfill, F. (2004). The outcome of pregnancies in 182 women with threatened miscarriage. Arch. Gynecol. Obstet., 270, 86-90. DOI:10.1007/s00404-003-0475-z.

Goldenberg, R.L., Hauth, J.C., & Andrews, W.W. (2000). Intrauterine infection and preterm delivery. N. Engl. J. Med., 342 (20), 1500-1507. DOI:10.1056/NEJM200005183422007.

(2007). Preterm birth: causes, consequences, and prevention. Behrman R.E., & Butler, A.S. (Eds.), Institute of Medicine (US) Committee on understanding premature birth and assuring healthy outcomes. Washington (DC): National Academies Press (US). DOI:10.17226/11622. Retrieved from: https://www.ncbi.nlm.nih.gov/books/NBK11362.

Mathews, T.J., & MacDorman, M.F. (2008). Infant mortality statistics from the 2005 period linked birth/infant death data set. Natl. Vital. Stat. Rep., 30, 57, 1-32.

Prince, A.L., Chu, D.M., Seferovic, M.D., Antony, K.M., Ma, J., & Aagaard, K.M. (2015). The perinatal microbiome and pregnancy: moving beyond the vaginal microbiome. Cold. Spring. Harb. Perspect. Med., 5 (6), a023051. DOI:10.1101/cshperspect.a023051.

Macintyre, D.A., Chandiramani, M., Lee, Y.S., Kindinger, L., Smith, A., Angelopoulos, N., …, & Bennett, P.R. (2015). The vaginal microbiome during pregnancy and the postpartum period in a European population. Sci. Rep., 5, 8988. DOI:10.1038/srep08988.

Wei, S.Q., Fraser, W., & Luo, Z.C. (2010). Inflammatory cytokines and spontaneous preterm birth in asymptomatic women: a systematic review. Obstet. Gynecol., 116 (2 Pt 1), 393-401. DOI:10.1097/AOG.0b013e3181e6dbc0.

Xu, F., Du, X., & Xie, L. (2015). Vaginitis in pregnancy is related to adverse perinatal outcome. Pak. J. Med. Sci., 31 (3), 582-586. DOI:10.12669/pjms.313.6752.

Bhatt, P., & Vidyashree, R. (2020). Clinicopathological vaginal discharge among pregnant women: Pattern of occurrence and associated complications. Indian J. Obstet. Gynecol. Res., 7 (2), 193-195. DOI:10.18231/j.ijogr.2020.040.

Işik, G., Demirezen, Ş., Dönmez, H.G., & Beksaç, M.S. (2016). Bacterial vaginosis in association with spontaneous abortion and recurrent pregnancy losses. J Cytol., 33 (3), 135-140. DOI:10.4103/0970-9371.188050.

Nigeen, W., Bhat, A.S., Gulzar, K., & Taing, S. (2015). Correlation of bacterial vaginosis with preterm labour: a case control study. Int. J. Reprod. Contracept. Obstet. Gynecol., 4, 1868-1874. DOI:10.18203/2320-1770.ijrcog20151276.

Ibrahim, S., Bukar, M., & Audu, B.M. (2016). Management of abnormal vaginal discharge in pregnancy. In eBook: Genital Infections and Infertility, M. Darwish Ed. Retrieved from: https://www.intechopen.com/books/genital-infections-and-infertility/management-of-abnormal-vaginal-discharge-in-pregnancy. DOI:10.5772/62599.

Horban, N.Y., Vovk, I.B., Lysiana, T.O., Ponomariova, I.H., & Zhulkevych, I.V. (2019). Peculiarities of uterine cavity biocenosis in patients with different types of endometrial hyperproliferative pathology. J. Med. Life., 12 (3), 266-270.

Koumans, E.H., Markowitz, L.E., & Hogan, V. (2002). Indications for therapy and treatment recommendations for bacterial vaginosis in nonpregnant and pregnant women: a synthesis of data. Clin. Infect. Dis., 35 (2), S152-S172. DOI:10.1086/342103.

Kamga, Y.M., Ngunde, J.P., & Akoachere, J.K.T. (2019). Prevalence of bacterial vaginosis and associated risk factors in pregnant women receiving antenatal care at the Kumba Health District (KHD), Cameroon. BMC. Pregnancy Childbirth, 19 (1), 166. DOI:10.1186/s12884-019-2312-9.

Desseauve, D., Chantrel, J., Fruchart, A., Khoshnood, B., Brabant, G., Ancel, P.Y., & Subtil, D. (2012). Prevalence and risk factors of bacterial vaginosis during the first trimester of pregnancy in a large French population-based study. Eur. J. Obstet. Gynecol. Reprod. Biol., 163 (1), 30-34. DOI:10.1016/j.ejogrb.2012.04.007.

Afolabi, B.B., Olusanjo, E.M., & Oyinlola, O.O. (2016). Bacterial vaginosis and pregnancy outcome in Lagos, Nigeria. Open. Forum. Infect. Dis., 3 (1), ofw030. DOI:10.1093/ofid/ofw030.

Nelson, D.B., Hanlon, A.L., Wu, G., Liu, C., & Fredricks, D.N. (2015). First trimester levels of bv-associated bacteria and risk of miscarriage among women early in pregnancy. Matern. Child. Health J., 19 (12), 2682-2687. DOI:10.1007/s10995-015-1790-2.

Savicheva, A.M., Vorobeva, N.E., Vagoras, A., Sokolovskiy, E., Gallen, A., & Domeyka, M. (2008). Ispolzovanie metoda pryamoy mikroskopii urogenitalnykh mazkov na ambulatornom priyome s tselyu optimizatsii diagnostiki urogenitalnyih infektsiy [Using direct microscopy of urogenital smears at an outpatient clinic to optimize the diagnosis of urogenital infections]. Trudnyiy patsient – Difficult Patient, 6 (1), 9-12 [in Russian].

Colugnati, F.A., Staras, S.A., Dollard, S.C., & Cannon, M.J. (2007). Incidence of cytomegalovirus infection among the general population and pregnant women in the United States. BMC. Infect. Dis., 7, 71. DOI:10.1186/1471-2334-7-71.

Guerra, A.B., Siravenha, L.Q., Laurentino, R.V., Feitosa, R.N.M., Azevedo, V.N., & Vallinoto, A.C.R. (2018). Seroprevalence of HIV, HTLV, CMV, HBV and rubella virus infections in pregnant adolescents who received care in the city of Belem, Para, Northern Brazil. BMC. Pregnancy Childbirth, 18 (1), 169-169. DOI: 10.1186/s12884-018-1753-x.

Jin, Q., Su, J., & Wu, S. (2017). Cytomegalovirus Infection among pregnant women in beijing: seroepidemiological survey and intrauterine transmissions. Microbiol. Biotechnol., 27 (5), 1005-1009. DOI:10.4014/jmb.1612.12020.

Torii, Y., Yoshida, S., Yanase, Y., Mitsui, T., Horiba, K., & Okumura, T., (2017). Serological screening of immunoglobulin M and immunoglobulin G during pregnancy for predicting congenital cytomegalovirus infection. BMC. Pregnancy Childbirth., 19, 205. DOI:10.1186/s12884-019-2360-1.

Patton, M.E., Bernstein, K., Liu, G., Zaidi, A., & Markowitz, L.E. (2018). Seroprevalence of herpes simplex virus types 1 and 2 among pregnant women and sexually active, nonpregnant women in the united states. Clin. Infect. Dis., 67 (10), 1535-1542. DOI:10.1093/cid/ciy318.

Okonko, I.O., & Cookey, T.I. (2015). Seropositivity and determinants of immunoglobulin-G (IgG) antibodies against Herpes simplex virus (HSV) types -1 and -2 in pregnant women in Port Harcourt, Nigeria. Afr. Health. Sci., 15 (3), 737-747. DOI:10.4314/ahs.v15i3.6.

Marchi, S., Trombetta, C.M., Gasparini, R., Temperton, N., & Montomoli, E. (2017). Epidemiology of herpes simplex virus type 1 and 2 in Italy: a seroprevalence study from 2000 to 2014. J. Prev. Med. Hyg., 58 (1), E27-E33.

Eskild, A., Bruu, A.-L., Stray-Pedersen, B., & Jenum, P. (2005). Epstein–Barr virus infection during pregnancy and the risk of adverse pregnancy outcome. BJOG: Int. J. Obstet. Gynaecol., 112: 1620-1624. DOI:10.1111/j.1471-0528.2005.00764.x.

Kostadinova, Ts., Ivanova, L., Tsaneva, D., Ermenlieva, N., Stoykova, Zh., & Tsankova, G. (2019). Distribution of Epstein-Barr virus among women of reproductive age and children up to 1 year in the Varna region. J. of IMAB., 25 (1), 2369-2372. DOI:10.5272/jimab.2019251.2369.

Karapetyan, T.E., Ankirskaya, A.S., & MuravYova, V.V. (2015). Bakterialnyiy vaginoz v pervom trimestre beremennosti [Bacterial vaginosis in the first trimester of pregnancy]. Meditsinskiy sovet – Medical Council, XX, 68-71. DOI:10.21518/2079-701X-2015-XX-68-71 [in Russian].

Nenadić, D.B., & Pavlović, M.D. (2008). Cervical fluid cytokines in pregnant women: relation to vaginal wet mount findings and polymorphonuclear leukocyte counts. Eur. J. Obstet. Gynecol. Reprod. Biol., 140 (2), 165-170. DOI:10.1016/j.ejogrb.2008.02.020.

Published

2021-03-04

How to Cite

Boychuk, A. V., & Romanenko, I. Y. (2021). SOME INDICATORS OF HUMORAL IMMUNITY AND MICROBIOCENOSIS CONDITION OF REPRODUCTIVE PATHWAYS OF WOMEN-INTERNALLY DISPLACED PERSONS WITH THREATENED MISCARRIAGE. Actual Problems of Pediatrics, Obstetrics and Gynecology, (2), 56–63. https://doi.org/10.11603/24116-4944.2020.2.11838

Issue

Section

OBSTETRICS AND GYNECOLOGY